Innoviva, Inc.INVANASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank50
5Y CAGR-8.6%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

5Y CAGR
-8.6%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
3 yr
Consecutive growthRecovering
PeriodValue
202518.52%
202415.54%
2023-6.30%
2022-15.45%
202116.35%
202029.03%
20190.00%
201820.16%
201762.63%
2016147.58%